The OHSU Foundation will receive $275,000 as part of nationwide settlement with Johnson & Johnson over deceptive marketing to fund an outreach cancer screening van for tribal communities.

Nima Nabavizadeh, M.D., provides expert commentary on multi-cancer early detection, or MCED, tests that are designed to screen for more than 50 types of cancer via a blood test.

Healio interviews Maria Fleseriu, M.D., regarding a clinical trial involving a new therapy for people with Cushing’s disease, diabetes and hypertension. She says, “This study highlights the need to adjust medications for comorbidities such as hypertension and diabetes after treatment for Cushing’s disease as improvement is expected in most but not all patients.”

In a Science article about a research team who identified an immune process in hippocampal neurons that could help explain how memories are maintained, Jacob Raber, Ph.D., says the finding linking the immune system to the formation of memory was striking: “It drives home the idea that you need immune activation. If you don't have any, it's not good. If you have too much, it's not good. If it's chronic, it's not good.”

Mark Pennesi, M.D., Ph.D., discusses how CRISPR gene editing improved vision for the majority of BRILLIANCE clinical trial participants with a rare, inherited form of blindness.

Bethany Samuelson Bannow, M.D., discusses her study of period products, the first to use actual blood, and her ongoing work to destigmatize periods.

Study led by Jane Zhu, M.D., finds patients of color nationwide are twice as likely to lose Medicaid coverage due to administrative issues.

The “Dare to Dream” program, created by the Leukemia & Lymphoma Society, aims to create better, safer and more effective treatments for pediatric blood cancer. Proceeds from the program will help fund research at OHSU and Seattle Children’s Hospital.

Luiz Bertassoni, Ph.D., D.D.S., co-authors a Portland Tribune op-ed republished on OHSU News on the Oregon-based Corvallis Microfluidics Tech Hub (CorMic), a consortium of academic, industry and community leaders striving to build a supportive environment that rewards cross-disciplinary collaboration: “Our future success with this technology will only come from strong, collaborative partnerships between industry and academia. By continuing to encourage, recognize and prioritize cross-industry collaboration in the microfluidics industry, Oregon is poised to transform the future of health care.”

At a recent Huntington’s Disease Society of America convention, Angelina Ciavarella, PT, describes how exercise helps people with Huntington's maintain mobility and function: “I think a common misconception with [Huntington’s disease] is that people can’t make changes or improvements, and that’s absolutely not true, especially in those early- or mid-stages” of the disease, emphasizing every body is different and constitutes enough exercise varies from person to person and over time.